FDA Approved: SIVEXTRO — Supplemental Application (Merck Sharp & Dohme LLC)

View source ↗

Summary

The FDA approved a supplemental application for SIVEXTRO (tedizolid phosphate) submitted by Merck Sharp & Dohme LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bacterial Skin and Skin Structure Infections

Drugs mentioned

• Sivextro (tedizolid)

Snippet

SUPPL AP for SIVEXTRO (TEDIZOLID PHOSPHATE)